A small-molecule approach to bone regenerative medicine in dentistry

Journal of Oral Biosciences

Volumn 52, Issue 2, 2010, Pages 107-118

  Egusa, Hiroshi ^a   Saeki, Makio ^a   Doi, Masanori ^a   Fukuyasu, Sho ^a   Matsumoto, Takuya ^a   Kamisaki, Yoshinori ^a   Yatani, Hirofumi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Bone regeneration; Chemical biology; Drug discovery; Regenerative dental medicine; Small molecules

Indexed keywords

EID: 77958552691     PISSN: 13490079     EISSN: None     Source Type: Journal    
DOI: 10.2330/joralbiosci.52.107     Document Type: Review

References (64)

1. Kirkwood, K. L.: Periodontal diseases and oral bone loss. In: Primer on the metabolic bone diseases and disorders of mineral metabolism.(ed. Rosen, C.J.), pp.510-513, American Society for Bone and Mineral Research, Washington, DC, 2008.
2. Atwood, D.A.: Reduction of residual ridges: a major oral disease entity. J. Prosthet. Dent. 26:266-279, 1971.
3. Darby, I., Chen, S. and De Poi, R.: Ridge preservation: what is it and when should it be considered. Aust. Dent J. 53:11-21, 2008.
4. Kaigler, D. and Mooney, D.: Tissue engineering's impact on dentistry. J. Dent. Educ. 65: 456-462, 2001.
5. Filho Cerruti, H., Kerkis, I., Kerkis, A., Tatsui, N.H., da Costa Neves, A., Bueno, D.F. and da Silva, M.C.: Allogenous bone grafts improved by bone marrow stem cells and platelet growth factors: Clinical case reports Artificial Organs 31:4 268-273, 2007(Pubitemid 46587676)
6. Meijer, G.J., de Bruijn, J.D., Koole, R. and van Blitterswijk, C.A.: Cell based bone tissue engineering in jaw defects. Biomaterials 29: 3053-3061, 2008.
7. Iizuka, T., Miller, S.C. and Marks, S.C., Jr.: Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats. J. Oral Pathol. Med. 21: 150-155, 1992.
8. Wikesjo, U.M., Polimeni, G. and Qahash, M.: Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives. Clin. Implant Dent. Relat. Res. 7:112-119, 2005.
9. Kitamura, M., Nakashima, K., Kowashi, Y., Fujii, T., Shimauchi, H., Sasano, T., Furuuchi, T., Fukuda, M., Noguchi, T., Shibutani, T., Iwayama, Y., Takashiba, S., Kurihara, H., Ninomiya, M., Kido, J., Nagata, T., Hamachi, T., Maeda, K., Hara, Y., Izumi, Y., Hirofuji, T., Imai, E., Omae, M., Watanuki, M. and Murakami, S.: Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS One 3: e2611, 2008.
10. Kantlehner, M., Schaffner, P., Finsinger, D., Meyer, J., Jonczyk, A., Diefenbach, B., Nies, B., Holzemann, G., Goodman, S.L. and Kessler, H.: Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 1: 107-114, 2000.
11. Egusa, H., Kaneda, Y., Akashi, Y., Hamada, Y., Matsumoto, T., Saeki, M., Thakor, D.K., Tabata, Y., Matsuura, N. and Yatani, H.: Enhanced bone regenera-tion via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts. Biomaterials 30: 4676-4686, 2009.
12. Franceschi, R.T., Ge, C., Xiao, G., Roca, H. and Jiang, D.: Transcriptional regulation of osteoblasts. Ann. N Y Acad. Sci. 1116: 196-207, 2007. (Pubitemid 350274351)
13. Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M. and Gutierrez, G.: Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946-1949, 1999. (Pubitemid 129515901)
14. Ayukawa, Y., Yasukawa, E., Moriyama, Y., Ogino, Y., Wada, H., Atsuta, I. and Koyano, K.: Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 107: 336-342, 2009.
15. Moriyama, Y., Ayukawa, Y., Ogino, Y., Atsuta, I., Todo, M., Takao, Y. and Koyano, K.: Local application of fluvastatin improves peri-implant bone quantity and mechanical properties: A rodent study. Acta Biomater. 6: 1610-1618, 2010.
16. Kugimiya, F., Yano, F., Ohba, S., Igawa, K., Nakamura, K., Kawaguchi, H. and Chung, U.I.: Mechanism of osteogenic induction by FK506 via BMP/Smad pathways. Biochem. Biophys. Res. Commun. 338: 872-879, 2005. (Pubitemid 41597724)
17. Ohba, S., Nakajima, K., Komiyama, Y., Kugimiya, F., Igawa, K., Itaka, K., Moro, T., Nakamura, K., Kawaguchi, H., Takato, T. and Chung, U.I.: A novel osteogenic helioxanthin-derivative acts in a BMP-dependent manner. Biochem. Biophys. Res. Commun. 357: 854-860, 2007. (Pubitemid 46693650)
18. Park, K.W., Waki, H., Kim, W.K., Davies, B.S., Young, S.G., Parhami, F. and Tontonoz, P.: The small molecule phenamil induces osteoblast differentiation and mineralization. Mol. Cell Biol. 29: 3905-3914, 2009.
19. Han, C.Y., Wang, Y., Yu, L., Powers, D., Xiong, X., Yu, V., Nguyen, Y., Jean, D.J., Jr. and Babij, P.: Small molecules with potent osteogenic-inducing activity in osteoblast cells. Bioorg. Med. Chem. Lett. 19: 1442-1445, 2009.
20. Yeo, H., Beck, L.H., McDonald, J.M. and Zayzafoon, M.: Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone 40: 1502-1516, 2007. (Pubitemid 46766648)
21. Tang, L., Ebara, S., Kawasaki, S., Wakabayashi, S., Nikaido, T. and Takaoka, K.: FK506 enhanced osteoblastic differentiation in mesenchymal cells. Cell Biol. Int. 26: 75-84, 2002. (Pubitemid 34174409)
22. Teitelbaum, S.L.: Bone resorption by osteoclasts. Science 289: 1504-1508, 2000.
23. Hall, T.J., Schaeublin, M., Jeker, H., Fuller, K. and Chambers, T.J.: The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem. Biophys. Res. Commun. 207: 280-287, 1995.
24. Takatsuna, H., Asagiri, M., Kubota, T., Oka, K., Osada, T., Sugiyama, C., Saito, H., Aoki, K., Ohya, K., Takayanagi, H. and Umezawa, K.: Inhibition of RANKL -induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J. Bone Miner. Res. 20: 653-662, 2005. (Pubitemid 40393074)
25. Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R.S., Kitamura, D., Kurosaki, T., Ellmeier, W. and Takayanagi, H.: Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132: 794-806, 2008. (Pubitemid 351312796)
26. Sato, K., Suematsu, A., Nakashima, T., Takemoto-Kimura, S., Aoki, K., Morishita, Y., Asahara, H., Ohya, K., Yamaguchi, A., Takai, T., Kodama, T., Chatila, T.A., Bito, H. and Takayanagi, H.: Regulation of osteoclast differentiation and function by the CaMKCREB pathway. Nat. Med. 12: 1410-1416, 2006. (Pubitemid 44924500)
27. Hirotani, H., Tuohy, N.A., Woo, J.T., Stern, P.H. and Clipstone, N.A.: The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J. Biol. Chem. 279: 13984-13992, 2004. (Pubitemid 38468932)
28. Igarashi, K., Hirotani, H., Woo, J.T. and Stern, P.H.: Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Bone 35: 47-56, 2004. (Pubitemid 38789147)
29. Murphy, M.G., Cerchio, K., Stoch, S.A., Gottesdiener, K., Wu, M. and Recker, R.: Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J. Clin. Endocrinol. Metab. 90: 2022-2028, 2005. (Pubitemid 40586234)
30. Hannon, R.A., Clack, G., Rimmer, M., Swaisland, A., Lockton, J.A., Finkelman, R.D. and Eastell, R.: Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple ascending dose phase I trial. J. Bone Miner. Res. 25: 463-471, 2010.
31. Bone, H.G., McClung, M.R., Roux, C., Recker, R.R.,Eisman, J.A., Verbruggen, N., Hustad, C.M., Dasilva, C., Santora, A.C. and Ince, B.A.: Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density. J. Bone Miner. Res. in press.
32. Okahashi, N., Nakamura, I., Jimi, E., Koide, M., Suda, T. and Nishihara, T.: Specific inhibitors of vacuolar H (+)-ATPase trigger apoptotic cell death of osteoclasts. J. Bone Miner. Res. 12: 1116-1123, 1997. (Pubitemid 27264226)
33. Niikura, K., Takeshita, N. and Chida, N.: A novel inhibitor of vacuolar ATPase, FR202126, prevents alveolar bone destruction in experimental periodontitis in rats. J. Toxicol. Sci. 30: 297-304, 2005. (Pubitemid 43087499)
34. Niikura, K., Takeshita, N. and Takano, M.A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application. J. Bone Miner. Res. 20: 1579-1588, 2005. (Pubitemid 41243547)
35. Kazami, S., Muroi, M., Kawatani, M., Kubota, T., Usui, T., Kobayashi, J. and Osada, H.: Iejimalides show anti-osteoclast activity via V-ATPase inhibition. Biosci. Biotechnol. Biochem. 70: 1364-1370, 2006. (Pubitemid 43961812)
36. Niikura, K., Nakajima, S., Takano, M. and Yamazaki, H.: FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats. Bone 40: 888-894, 2007. (Pubitemid 46386530)
37. Schaller, S., Henriksen, K., Sveigaard, C., Heegaard, A.M., Helix, N., Stahlhut, M., Ovejero, M.C., Johansen, J.V., Solberg, H., Andersen, T.L., Hougaard, D., Berryman, M., Shiodt, C.B., Sorensen, B.H., Lichtenberg, J., Christophersen, P., Foged, N.T., Delaisse, J.M., Engsig, M.T. and Karsdal, M.A.: The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation. J. Bone Miner. Res. 19: 1144-1153, 2004. (Pubitemid 41110567)
38. Yaffe, A., Fine, N., Alt, I. and Binderman, I.: The effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J. Periodontol. 66: 999-1003, 1995.
39. Bettany, J.T., Peet, N.M., Wolowacz, R.G., Skerry, T. M. and Grabowski, P.S.: Tetracyclines induce apoptosis in osteoclasts. Bone 27: 75-80, 2000. (Pubitemid 30365080)
40. Yaffe, A., Herman, A., Bahar, H. and Binderman, I.: Combined local application of tetracycline and bisphosphonate reduces alveolar bone resorption in rats. J. Periodontol. 74: 1038-1042, 2003. (Pubitemid 37038539)
41. Meraw, S.J., Reeve, C.M. and Wollan, P.C.: Use of alendronate in peri-implant defect regeneration. J. Periodontol. 70: 151-158, 1999. (Pubitemid 29140479)
42. Jimi, E., Takami, M., Hiraga, T., Nakamura, I., Urade, M. and Miyamoto, Y.: The light and dark side of bisphosphonates. J. Oral Biosci. 51: 177-187, 2009.
43. Keeling, D.J., Herslof, M., Ryberg, B., Sjogren, S. and Solvell, L.: Vacuolar H(+)-ATPases. Targets for drug discovery? Ann. N Y Acad. Sci. 834: 600-608, 1997. (Pubitemid 28009136)
44. Hojo, H., Igawa, K., Ohba, S., Yano, F., Nakajima, K., Komiyama, Y., Ikeda, T., Lichtler, A.C., Woo, J.T., Yonezawa, T., Takato, T. and Chung, U.I.: Development of high-throughput screening system for osteogenic drugs using a cell-based sensor. Biochem. Biophys. Res. Commun. 376: 375-379, 2008.
45. Benoit, D.S., Nuttelman, C.R., Collins, S.D. and Anseth, K.S.: Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 27: 6102-6110, 2006. (Pubitemid 44414974)
46. Kawatani, M., Okumura, H., Honda, K., Kanoh, N., Muroi, M., Dohmae, N., Takami, M., Kitagawa, M., Futamura, Y., Imoto, M. and Osada, H.: The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc. Natl. Acad. Sci. USA 105: 11691-11696, 2008.
47. Cai, M., Liu, X., Shao, J., Qi, J., Wang, J., Zhu, Y., Zhou, Q., Zhao, Q., Li, G., Liang, J., Lu, W.W. and Deng, L.: OIC-A006 promotes osteogenesis in vitro and in vivo. Pharmazie 63: 751-756, 2008.
48. Liu, Z., Shi, W., Ji, X., Sun, C., Jee, W.S., Wu, Y., Mao, Z., Nagy, T.R., Li, Q. and Cao, X.: Molecules mimicking Smad1 interacting with Hox stimulate bone formation. J. Biol. Chem. 279: 11313-11319, 2004. (Pubitemid 38401628)
49. Choi, Y., Kawazoe, Y., Murakami, K., Misawa, H. and Uesugi, M.: Identification of bioactive molecules by adipogenesis profiling of organic compounds. J. Biol. Chem. 278: 7320-7324, 2003. (Pubitemid 36800734)
50. Miyamoto, K., Suzuki, H., Yamamoto, S., Saitoh, Y., Ochiai, E., Moritani, S., Yokogawa, K., Waki, Y., Kasugai, S., Sawanishi, H. and Yamagami, H.: Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture. J. Bone Miner. Res. 18: 1471-1477, 2003. (Pubitemid 41070801)
51. Notoya, K., Nagai, H., Oda, T., Gotoh, M., Hoshino, T., Muranishi, H., Taketomi, S., Sohda, T. and Makino, H.: Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778. J. Pharmacol. Exp. Ther. 290: 1054-1064, 1999. (Pubitemid 29400244)
52. Rosa, A.L. and Beloti, M.M.: TAK-778 enhances osteoblast differentiation of human bone marrow cells via an estrogen-receptor-dependent pathway. J. Cell Biochem. 91: 749-755, 2004.
53. Song, C., Guo, Z., Ma, Q., Chen, Z., Liu, Z., Jia, H. and Dang, G.: Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem. Biophys. Res. Commun. 308: 458-462, 2003. (Pubitemid 36945513)
54. Song, C., Wang, J., Song, Q., Li, X., Chen, Z., Ma, Q., Liu, Z., Jia, H. and Dang, G.: Simvastatin induces estrogen receptor-alpha (ER-alpha) in murine bone marrow stromal cells. J. Bone Miner. Metab. 26: 213-217, 2008. (Pubitemid 351677840)
55. Maeda, T., Matsunuma, A., Kawane, T. and Horiuchi, N.: Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 280: 874-847, 2001.
56. Ogawa, T., Tokuda, M., Tomizawa, K., Matsui, H., Itano, T., Konishi, R., Nagahata, S. and Hatase, O.: Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells. Biochem. Biophys. Res. Commun. 249: 226-230, 1998. (Pubitemid 28418724)
57. Lee, K.W., Yook, J.Y., Son, M.Y., Kim, M.J., Koo, D.B., Han, Y.M. and Cho, Y.S.: Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev. 19: 557-568, 2010.
58. Woo, J.T., Kawatani, M., Kato, M., Shinki, T., Yonezawa, T., Kanoh, N., Nakagawa, H., Takami, M., Lee, K.H., Stern, P.H., Nagai, K. and Osada, H.: Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Proc. Natl. Acad. Sci. USA 103: 4729-4734, 2006.
59. Woo, J.T., Nakagawa, H., Krecic, A.M., Nagai, K., Hamilton, A.D., Sebti, S.M. and Stern, P.H.: Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor -alpha (TNF-alpha). Biochem. Pharmacol. 69: 87-95, 2005. (Pubitemid 39592875)
60. Yamagami, H., Nishioka, T., Ochiai, E., Fukushima, K., Nomura, M., Kasugai, S., Moritani, S., Yokogawa, K. and Miyamoto, K.: Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. Biochem. Pharmacol. 66: 801-807, 2003. (Pubitemid 37011419)
61. Nakagawa, H., Takami, M., Udagawa, N., Sawae, Y., Suda, K., Sasaki, T., Takahashi, N., Wachi, M., Nagai, K. and Woo, J.T.: Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts. Bone 33: 443-455, 2003. (Pubitemid 37103261)
62. Woo, J.T., Kasai, S., Stern, P.H. and Nagai, K.: Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J. Bone Miner. Res. 15: 650-662, 2000. (Pubitemid 30174019)
63. Gao, Y.H. and Yamaguchi, M.: Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol. 58: 767-772, 1999. (Pubitemid 29329525)
64. Nakamura, I., Takahashi, N., Sasaki, T., Tanaka, S., Udagawa, N., Murakami, H., Kimura, K., Kabuyama, Y., Kurokawa, T., Suda, T. and Fukui, Y.: Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett. 361: 79-84, 1995.